Physician profile
James E Kemmler
NPI 1245223635
$3,121.15
in general payments reported to CMS, 2019-2025
14 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,455 · 2020: $22.17 · 2021: $20.98 · 2022: $71.47 · 2023: $141 · 2024: $225 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cdc Medical LLC | $1,824.36 | 2019 | |
| Arthrex, INC. | $466.50 | 2019 | |
| Stryker Corporation | $458.12 | 2019-2025 | Pangea, Gamma, Variax |
| Globus Medical, INC. | $95.22 | 2023 | Troch Nail |
| Rock Medical Orthopedics, INC. | $59.79 | 2021-2024 | |
| Pacira Pharmaceuticals Incorporated | $45.56 | 2023 | Iovera, Zilretta, Exparel |
| Davol INC. | $45.34 | 2022 | |
| Pacira Therapeutics, INC. | $42.56 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.01 | 2019 | |
| Heron Therapeutics, INC. | $21.76 | 2022 | |
| Orthofix Medical, INC. | $12.39 | 2019 | |
| Allergan, INC. | $11.20 | 2020 | |
| Endo Pharmaceuticals INC. | $10.97 | 2020 | |
| Microaire Surgical Instruments LLC | $4.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kemmler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.